Department of Pharmaceutical Sciences, International University of Health and Welfare, Fukuoka Japan.
Kyushu University Hospital, Medical Information Center, Fukuoka Japan.
Stud Health Technol Inform. 2022 Jun 6;290:1132-1133. doi: 10.3233/SHTI220303.
In Japan, the polypharmacy reduction policy for psychotropic drugs is intended to reduce the reimbursement of medical costs when "three or more types of psychotropic drugs" are prescribed. However, non-polypharmacy patients who need multiple drugs are also comprehensively evaluated. This study demonstrated that the polypharmacy reduction policy for psychotropic drugs is associated with reductions of the amounts of in-hospital prescriptions for patients using antidepressants, antipsychotics, anxiolytics, and benzodiazepines.
在日本,减少精神药物的多药治疗政策旨在减少“三种或更多种精神药物”处方时的医疗费用报销。然而,也对需要多种药物的非多药治疗患者进行了全面评估。本研究表明,减少精神药物的多药治疗政策与使用抗抑郁药、抗精神病药、抗焦虑药和苯二氮䓬类药物的住院患者的处方量减少有关。